LDLR and atherosclerosis: When Tregs treated with oxPAPC were transferred into hyperlipidaemic low-density lipoprotein receptor (LDLr) knockout mice, they lost their protective ability to prevent the progression of atherosclerosis, suggesting that oxPAPC impairs the function and differentiation of Tregs [124] (figure 2c).